AU512782B2 - Compositions comprising heparin andan ergot alkaloid - Google Patents

Compositions comprising heparin andan ergot alkaloid

Info

Publication number
AU512782B2
AU512782B2 AU20249/76A AU2024976A AU512782B2 AU 512782 B2 AU512782 B2 AU 512782B2 AU 20249/76 A AU20249/76 A AU 20249/76A AU 2024976 A AU2024976 A AU 2024976A AU 512782 B2 AU512782 B2 AU 512782B2
Authority
AU
Australia
Prior art keywords
andan
heparin
compositions
ergot alkaloid
ergot
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU20249/76A
Other versions
AU2024976A (en
Inventor
H. and Welzel D Bohlmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2554533A external-priority patent/DE2554533C3/en
Priority claimed from DE19762625403 external-priority patent/DE2625403A1/en
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU2024976A publication Critical patent/AU2024976A/en
Application granted granted Critical
Publication of AU512782B2 publication Critical patent/AU512782B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Electronic Switches (AREA)
AU20249/76A 1975-12-04 1976-12-03 Compositions comprising heparin andan ergot alkaloid Expired AU512782B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE2554533A DE2554533C3 (en) 1975-12-04 1975-12-04 Use of dihydroergotamine and heparin
DEDE2554533 1975-12-04
DE19762625403 DE2625403A1 (en) 1976-06-05 1976-06-05 Antithrombotic association of medicaments - contains heparin and an ergoline-(8)-carboxylic acid peptidic amide esp. dihydroergotamine opt. with polyvinyl pyrrolidone
DEDE2625403 1976-06-05

Publications (2)

Publication Number Publication Date
AU2024976A AU2024976A (en) 1978-06-08
AU512782B2 true AU512782B2 (en) 1980-10-30

Family

ID=25769698

Family Applications (1)

Application Number Title Priority Date Filing Date
AU20249/76A Expired AU512782B2 (en) 1975-12-04 1976-12-03 Compositions comprising heparin andan ergot alkaloid

Country Status (17)

Country Link
JP (1) JPS5270031A (en)
AU (1) AU512782B2 (en)
CS (1) CS216164B2 (en)
ES (1) ES453869A1 (en)
FR (1) FR2333513A1 (en)
GB (1) GB1557331A (en)
HK (1) HK3083A (en)
IE (1) IE44359B1 (en)
IL (1) IL51043A (en)
IT (1) IT7827782A0 (en)
MY (1) MY8400064A (en)
NL (1) NL172401C (en)
NZ (1) NZ182790A (en)
PH (1) PH12759A (en)
PT (1) PT65919B (en)
SE (1) SE441142B (en)
SG (1) SG63482G (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570658B2 (en) * 1982-12-10 1988-03-24 Sandoz Ltd. Pharmaceutical compositions of ergot alkaloids and heparin

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2809618A1 (en) * 1978-03-06 1979-09-20 Sandoz Ag NEW THERAPEUTIC PREPARATION AND METHOD FOR THE PRODUCTION THEREOF

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570658B2 (en) * 1982-12-10 1988-03-24 Sandoz Ltd. Pharmaceutical compositions of ergot alkaloids and heparin

Also Published As

Publication number Publication date
NL172401C (en) 1983-09-01
CS216164B2 (en) 1982-10-29
IE44359L (en) 1977-06-04
HK3083A (en) 1983-01-20
GB1557331A (en) 1979-12-05
ES453869A1 (en) 1978-01-16
NL172401B (en) 1983-04-05
MY8400064A (en) 1984-12-31
NL7613316A (en) 1977-06-07
JPS5270031A (en) 1977-06-10
AU2024976A (en) 1978-06-08
PT65919A (en) 1977-01-01
SE7613252L (en) 1977-06-05
FR2333513B1 (en) 1980-03-28
NZ182790A (en) 1979-03-16
PT65919B (en) 1978-07-05
SE441142B (en) 1985-09-16
SG63482G (en) 1983-09-09
FR2333513A1 (en) 1977-07-01
IT7827782A0 (en) 1978-09-18
IE44359B1 (en) 1981-11-04
PH12759A (en) 1979-08-09
IL51043A0 (en) 1977-02-28
IL51043A (en) 1980-02-29

Similar Documents

Publication Publication Date Title
AU520754B2 (en) Nasal ergot alkaloid compositions
AU500961B2 (en) Squelch circuit
AU508628B2 (en) Ergot alkaloid compositions
AU514288B2 (en) Ergoline derivatives
AU511507B2 (en) Funcationalised adenine derivatives
AU534051B2 (en) Ergot alkaloid slow-release compositions
PH12202A (en) Ergot derivative
AU3281078A (en) Ergot derivatives
AU512782B2 (en) Compositions comprising heparin andan ergot alkaloid
GB1485738A (en) Ergot alkaloids
AU506218B2 (en) Ergot alkaloids
AU545645B2 (en) Ergot alkaloid
AU520738B2 (en) 8-ureidomethyl ergoline derivatives
AU2104177A (en) Ergoline derivatives
HK81085A (en) Pharmaceutical compositions containing an ergot alkaloid and heparin
AU502091B2 (en) Urea-formaldehyde compositions
AU6302180A (en) Ergot alkaloid
AU520880B2 (en) Ergoline derivatives
PT65756B (en) Alkaloid derivative
AU502928B2 (en) 8-cyanoethyl ergolines
AU2103877A (en) Ergot alkaloid derivatives
AU513467B2 (en) Antihypertensive composition
AU513774B2 (en) Ergoline derivatives
AU495082B2 (en) 7-(alpha-uredoacylamido)-methoxycephalosporins